Vemurafenib in the French temporary authorization for use metastatic melanoma cohort: a single-centre trial.
Fennira F, Pagès C, Schneider P, Sidina I, Viguier M, Basset-Seguin N, Madjlessi-Ezra N, Madelaine I, Bagot M, Battistella M, Porcher R, Mourah S, Lebbé C.
Fennira F, et al. Among authors: madelaine i.
Melanoma Res. 2014 Feb;24(1):75-82. doi: 10.1097/CMR.0000000000000034.
Melanoma Res. 2014.
PMID: 24241686